News
PARD
0.0000
NaN%
--
Weekly Report: what happened at PARD last week (0908-0912)?
Weekly Report · 09/15 10:28
Weekly Report: what happened at PARD last week (0901-0905)?
Weekly Report · 09/08 10:30
Weekly Report: what happened at PARD last week (0825-0829)?
Weekly Report · 09/01 10:27
Weekly Report: what happened at PARD last week (0818-0822)?
Weekly Report · 08/25 10:34
Weekly Report: what happened at PARD last week (0811-0815)?
Weekly Report · 08/18 10:29
Weekly Report: what happened at PARD last week (0804-0808)?
Weekly Report · 08/11 10:33
Weekly Report: what happened at PARD last week (0728-0801)?
Weekly Report · 08/04 10:36
Weekly Report: what happened at PARD last week (0721-0725)?
Weekly Report · 07/28 10:37
Weekly Report: what happened at PARD last week (0714-0718)?
Weekly Report · 07/21 10:29
Weekly Report: what happened at PARD last week (0707-0711)?
Weekly Report · 07/14 10:35
Weekly Report: what happened at PARD last week (0630-0704)?
Weekly Report · 07/07 10:30
Weekly Report: what happened at PARD last week (0623-0627)?
Weekly Report · 06/30 10:34
Weekly Report: what happened at PARD last week (0616-0620)?
Weekly Report · 06/23 10:29
Weekly Report: what happened at PARD last week (0609-0613)?
Weekly Report · 06/16 10:34
Weekly Report: what happened at PARD last week (0602-0606)?
Weekly Report · 06/09 10:35
Weekly Report: what happened at PARD last week (0526-0530)?
Weekly Report · 06/02 10:40
Weekly Report: what happened at PARD last week (0519-0523)?
Weekly Report · 05/26 10:40
Weekly Report: what happened at PARD last week (0512-0516)?
Weekly Report · 05/19 10:33
Weekly Report: what happened at PARD last week (0505-0509)?
Weekly Report · 05/12 10:34
Weekly Report: what happened at PARD last week (0428-0502)?
Weekly Report · 05/05 10:35
More
Webull provides a variety of real-time PARD stock news. You can receive the latest news about Poniard Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About PARD
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.